| 1 Woche | 1 Monat | 3 Monate | Lfd. Jahr | 1 Jahr | 3 Jahre | |
| Kurs | 20,265 $ | 22,17 $ | 17,66 $ | 16,075 $ | 12,56 $ | 17,7856 $ |
| Änderung | -7,20% | -15,18% | +6,48% | +16,98% | +49,72% | +5,73% |
| Zeit | Titel | Quelle |
| 13.05.26 | Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results | PR Newswire |
| 05.01.26 | Protalix BioTherapeutics Letter to Stockholders | PR Newswire |
| 13.11.25 | Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results | PR Newswire |
| 14.08.25 | Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results | PR Newswire |
| 07.08.25 | Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025 | PR Newswire |
| 30.06.25 | Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes® | PR Newswire |
| Kaufen | Halten | Verkaufen | |
|---|---|---|---|
| Analysten | 0 | 0 | 0 |
| Markt-Lotsen | 0 | 0 | 0 |
